The oncology sector – like most of the healthcare sector – has been struggling post-COVID boom, faltering in the face of a tight financial market reluctant.
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) will present two of its abstracts at an annual conference of the International Society of Cell & Gene Therapy (ISCT) in France later this month.
PRESS RELEASE Antion Biosciences Presents Preclinical Data at International Society of Cell & Gene Therapy (ISCT) Annual Meeting Data demonstrates successful silencing of five target genes using A.